© 2020 MJH Life Sciences and Medical Economics. All rights reserved.
July 27, 2020
A trio of experts will discuss the prospects of a handful of COVID-19 vaccine candidates which are entering phase 3 trials.
July 22, 2020
The deal is for the companies to supply up to 600 million doses of a MRNA-based vaccine candidate.
July 20, 2020
The candidate is a joint effort of Oxford University and AstraZeneca.